Lincoln International and a group of its current shareholders said Monday they plan to pursue an initial public offering in the United States that could generate as much as $421 million, according to the company's filing.
The firm registered the sale of a total 21,049,988 shares for listing on the New York Stock Exchange, proposing an offering price between $18 and $20 per share. Of the shares in the filing, Lincoln International intends to sell 20,604,046 shares of its Class A common stock, while existing stockholders have filed to sell 445,942 shares.
Management has indicated the company will seek a listing under the symbol LCLN. The registration names Goldman Sachs & Co. LLC and Morgan Stanley as lead bookrunners tasked with managing the offering and building the order book.
Additional underwriting support is included in the filing. The group of underwriters listed in connection with the deal comprises BMO Capital Markets, Citizens Capital Markets, Evercore ISI, Keefe, Bruyette & Woods, and Wolfe | Nomura Alliance.
Lincoln International describes itself in the filing as a financial services firm that provides advisory services and financing solutions for middle-market transactions. The company says it concentrates on private capital market activity and delivers advisory services to private equity investors, private credit investors, and owners of private companies.
Deal structure and market placement
The proposed structure splits the offering between the company's sale of Class A shares and a smaller sale by existing shareholders. The proposed $18 to $20 range establishes a potential maximum raise of $421 million if all shares are sold at the top of that band.
Underwriting syndicate
Goldman Sachs & Co. LLC and Morgan Stanley are positioned as the lead underwriters, with a broader syndicate including BMO Capital Markets, Citizens Capital Markets, Evercore ISI, Keefe, Bruyette & Woods, and Wolfe | Nomura Alliance supporting the transaction.
Details available in the filing describe the firm's focus and the share allocation, but the filing does not provide additional commentary on timing beyond the registration or on the ultimate pricing decision, which will depend on market conditions and final determinations by the company and its underwriters.